LabNote is an AI-powered research platform designed to innovate and streamline the entire research workflow. It combines an electronic lab notebook (ELN), collaborative data management, and specialized tools like an AI research assistant (Labnote Scholar) and automated non-clinical documentation (Labnote Preclindoc), empowering researchers to focus on discovery.
Rayyan is an AI-powered platform designed for researchers to accelerate systematic and literature reviews. It streamlines the process with features like automated screening, duplicate detection, and real-time collaboration, saving researchers up to 90% of their screening time. Trusted by over 800,000 users, it supports the entire review lifecycle from data import to final reporting.
LabNote is an AI-powered research platform designed to innovate and streamline the entire research workflow. It combines an electronic lab notebook (ELN), collaborative data management, and specialized tools like an AI research assistant (Labnote Scholar) and automated non-clinical documentation (Labnote Preclindoc), empowering researchers to focus on discovery.
Rayyan is an AI-powered platform designed for researchers to accelerate systematic and literature reviews. It streamlines the process with features like automated screening, duplicate detection, and real-time collaboration, saving researchers up to 90% of their screening time. Trusted by over 800,000 users, it supports the entire review lifecycle from data import to final reporting.
| Feature | LabNote | Rayyan |
|---|---|---|
| Primary category | Data Management | Academic |
| Added | 2025-08-11 | 2025-09-11 |
| Pricing | Freemium | Freemium |
| Official website | www.labnote.co | rayyan.ai |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 3.4K | 1.1M |
| Monthly growth | -21% | -4% |
| Favorites | 124 | 128 |
| Details | View details | View details |
Compare LabNote and Rayyan by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the LabNote vs Rayyan monthly traffic comparison, LabNote currently shows 3.4K visits and Rayyan shows 1.1M; Rayyan has about 324.3 times the visible traffic of LabNote, an absolute difference of about 1.1M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇰🇷Korea, Republic of | 100% | 3.4K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 100% | 3.4K |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 32.99% | 359.1K |
| 🇧🇷Brazil | 31.2% | 339.6K |
| 🇬🇧United Kingdom | 20.31% | 221K |
| 🇵🇰Pakistan | 7.75% | 84.3K |
| 🇵🇹Portugal | 7.75% | 84.3K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 80.86% | 880.1K |
| Referral | 14.66% | 159.6K |
| 4.48% | 48.8K |
This in-depth LabNote vs Rayyan comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. LabNote is primarily listed under “Data Management”, while Rayyan is primarily listed under “Academic”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (LabNote: Data Management; Rayyan: Academic); Monthly visits (LabNote: 3.4K; Rayyan: 1.1M); Monthly growth (LabNote: -21%; Rayyan: -4%); Favorites (LabNote: 124; Rayyan: 128); Website (LabNote: www.labnote.co; Rayyan: rayyan.ai). These facts are more useful for selection than brand visibility alone.
In the LabNote vs Rayyan monthly traffic comparison, LabNote currently shows 3.4K visits and Rayyan shows 1.1M; Rayyan has about 324.3 times the visible traffic of LabNote, an absolute difference of about 1.1M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Rayyan first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
LabNote and Rayyan currently overlap in shared categories: Research; shared tags: collaboration and research. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
LabNote's unique categories/tags are Data Management, Laboratory Information Management, AI assistant, biotech, CRO, data management, electronic lab notebook, and ELN; Rayyan's are Academic, academic, AI screening, data analysis, deduplication, literature review, medical research, and Prisma. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
LabNote has no verified rating, 0 comments, 124 favorites, and 116 likes；Rayyan has no verified rating, 0 comments, 128 favorites, and 116 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put LabNote on the priority trial list when the task aligns with “Data Management” and especially Data Management, Laboratory Information Management, AI assistant, biotech, CRO, and data management. This follows recorded positioning and does not imply unlisted capabilities are absent.
LabNote also currently records: pricing is freemium, product type is website, 3.4K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Rayyan on the priority trial list when the task aligns with “Academic” and especially Academic, academic, AI screening, data analysis, deduplication, and literature review, or the users include Academic, Data Analyst, Librarian, and Medical Professional. This follows recorded positioning and does not imply unlisted capabilities are absent.
Rayyan also currently records: pricing is freemium, product type is website, 1.1M verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in LabNote and Rayyan, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
